Filing Details
- Accession Number:
- 0001209191-12-049402
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-15 16:44:01
- Reporting Period:
- 2012-10-11
- Filing Date:
- 2012-10-15
- Accepted Time:
- 2012-10-15 16:44:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197032 | F Ian Smith | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-10-11 | 7,680 | $28.84 | 31,848 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-10-11 | 6,363 | $18.93 | 38,211 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-10-11 | 14,043 | $60.00 | 24,168 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2012-10-11 | 7,680 | $0.00 | 7,680 | $28.84 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2012-10-11 | 6,363 | $0.00 | 6,363 | $18.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,570 | 2017-07-11 | No | 4 | M | Direct | |
| 0 | 2018-02-06 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,185 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
- Fully vested.
Billionaire Hedge Funds
